New stomach bug treatment showdown: which works better?
NCT ID NCT06340334
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different drug combinations to treat Helicobacter pylori, a stomach infection that can cause ulcers. About 400 adults took either a two-drug regimen (tegoprazan and amoxicillin) or a four-drug regimen (including bismuth and furazolidone). The goal was to see which treatment cleared the infection better and had fewer side effects like nausea or diarrhea.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FURAZOLIDONE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanjing First Hospital
Nanjing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a closer look at the stomach spot hidden infections?
- Which antibiotic combo wins against h. pylori? a Head-to-Head test
- Can customizing antibiotics beat stomach bug resistance?
- A supplement may tame the Gut-Wrenching side effects of h. pylori therapy
- Could a fecal transplant beat a stubborn stomach bug?
- AI eye on stomach cancer: 6,000-Person trial tests smarter scopes